Literature DB >> 12464660

Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

David A Lomas1, Ravi Mahadeva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464660      PMCID: PMC151637          DOI: 10.1172/JCI16782

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  32 in total

1.  Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.

Authors:  B Gooptu; B Hazes; W S Chang; T R Dafforn; R W Carrell; R J Read; D A Lomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease.

Authors:  P R Elliott; X Y Pei; T R Dafforn; D A Lomas
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

3.  6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.

Authors:  Ravi Mahadeva; Timothy R Dafforn; Robin W Carrell; David A Lomas
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

Review 4.  Alpha1-antitrypsin deficiency--a model for conformational diseases.

Authors:  Robin W Carrell; David A Lomas
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

Review 5.  Dissecting glycoprotein quality control in the secretory pathway.

Authors:  C M Cabral; Y Liu; R N Sifers
Journal:  Trends Biochem Sci       Date:  2001-10       Impact factor: 13.807

6.  Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.

Authors:  Didier Belorgey; Damian C Crowther; Ravi Mahadeva; David A Lomas
Journal:  J Biol Chem       Date:  2002-03-05       Impact factor: 5.157

7.  Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency.

Authors:  G L Devlin; H Parfrey; D J Tew; D A Lomas; S P Bottomley
Journal:  Am J Respir Cell Mol Biol       Date:  2001-06       Impact factor: 6.914

Review 8.  Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  S D Shapiro
Journal:  Clin Chest Med       Date:  2000-12       Impact factor: 2.878

9.  The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.

Authors:  J H Teckman; J Burrows; T Hidvegi; B Schmidt; P D Hale; D H Perlmutter
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

10.  Chemotactic activity of elastin-derived peptides.

Authors:  R M Senior; G L Griffin; R P Mecham
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more
  87 in total

Review 1.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

Authors:  Arthur Horwich
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  The cellular response to aggregated proteins associated with human disease.

Authors:  David H Perlmutter
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 3.  Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury.

Authors:  David H Perlmutter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 4.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 5.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

6.  Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.

Authors:  Didde Haslund; Laura Barrett Ryø; Sara Seidelin Majidi; Iben Rose; Kristian Alsbjerg Skipper; Tue Fryland; Anja Bille Bohn; Claus Koch; Martin K Thomsen; Yaseelan Palarasah; Thomas J Corydon; Anette Bygum; Lene N Nejsum; Jacob Giehm Mikkelsen
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

7.  Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.

Authors:  Kristina B Kruse; Amy Dear; Erin R Kaltenbrun; Brandan E Crum; Peter M George; Stephen O Brennan; Ardythe A McCracken
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 8.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

Review 9.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

10.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.